Skip to content

Medical emergency? What to do

Drug may keep transplanted kidneys healthier longer

3-RXPublished August 25, 20053 min read

Key points

  • Transplanted kidneys may survive three or four years longer when treated with an experimental Bristol-Myers Squibb Co. drug instead of the standard drug cyclosporine, a study released on Wednesday showed.
  • But tests showed that the organs functioned much better when receiving the experimental drug belatacept, according to the study published in the New England Journal of Medicine.
  • Of the 15 named authors, four are employees of the company and seven have financial ties to it.
  • The problem is that cyclosporine-type drugs, while preventing the body from rejecting an organ, "can produce toxicity within the kidney, and ultimately many kidneys suffer significant damage.

Transplanted kidneys may survive three or four years longer when treated with an experimental Bristol-Myers Squibb Co. drug instead of the standard drug cyclosporine, a study released on Wednesday showed.

A test of 218 transplant recipients at 22 centers in North America and Europe found that the six-month rejection rate for kidneys treated with either drug was equally low.

But tests showed that the organs functioned much better when receiving the experimental drug belatacept, according to the study published in the New England Journal of Medicine.

Journal editors Julie Ingelfinger and Robert Schwartz cautioned that doctors "will need much more experience with belatacept before recommending it as a routine replacement for cyclosporine."

Bristol-Myers Squibb paid for the study. Of the 15 named authors, four are employees of the company and seven have financial ties to it.

Cyclosporine "gives excellent short-term results. The problem is that over the long term, over the past 10 years, despite all the newer drugs that have been approved for transplantation, we have seen only a modest improvement in long-term organ survival," Flavio Vincenti, the chief author of the study, told Reuters.

The problem is that cyclosporine-type drugs, while preventing the body from rejecting an organ, "can produce toxicity within the kidney, and ultimately many kidneys suffer significant damage. So early on they do an excellent job, but over the long term they do not provide significant improvement in the life of the kidney," he said.

Cyclosporine, sold under the brand names Sandimmune or Neoral by Novartis, and related drugs also can promote heart disease.

Newer drugs like belatacept can be used without cyclosporine, said Vincenti of the University of California, San Francisco. The kidney function tests of the belatacept recipients "can be extrapolated to say these kidneys will last three to four years longer," he said.

The study did not directly assess long-term kidney survival. It was only designed to see if belatacept was inferior to cyclosporine over the short term.

The researchers found that both drugs made patients just as prone to infection and just as likely to develop cancer. And even though more cyclosporine recipients were taking blood pressure or cholesterol medicine, the blood pressures and cholesterol readings of the belatacept recipients were similar or slightly lower.

Vincenti said one advantage of belatacept is that it is given intravenously once a month so patients don't have to worry about taking pills every day. Some cyclosporine patients may skip their pills because of the side effects.

"You get assurance of compliance and the patient doesn't have to deal with the daily toxicities of some of the drugs," he said. "So this is a big improvement, I think."

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underUrine Problems
Diabetes

Metabolic syndrome predicts kidney disease

Having the so-called metabolic syndrome may raise the risk of chronic kidney disease in people with type 2 diabetes, researchers from China report. Metabolic syndrome refers to a cluster of risk factors for diabetes…

2 min read

Cancer

Men with Health Risk Behaviors Unaware of PSA Test

New research of 7,297 men in California, published in The Journal of Urology ®, shows that self-reported prostate-specific antigen (PSA) test awareness was lower in current smokers, physically inactive men and obese…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.